Harrison, L. et al. Low-to-moderate dosed cranial irradiation in young mice induces sex-specific metabolic disturbances later in life. Diabetes 74, 1775-1786 (2025)
Krischer, J.P.* et al. A comparative analysis of the sensitivity, specificity, concordance, and the 5-year predictive power of diabetes-related autoantibody assays. Diabetes 74, 1535-1546 (2025)
Ussar, S. Targeting adipose inflammation and energy expenditure to sustain metabolic health after weight loss. Diabetes 74, 1464-1465 (2025)
Cohrs, C.M. ; Chen, C. ; Atkinson, M.A.* ; Drotar, D.M.* & Speier, S. Bridging the Gap: Pancreas tissue slices from organ and tissue donors for the study of diabetes pathogenesis. Diabetes 73, 11-22 (2024)
Grace, S.L.* et al. Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes. Diabetes 73, 1583-1591 (2024)
Heinitz, S. et al. An E115A missense variant in CERS2 is associated with increased sleeping energy expenditure and hepatic insulin resistance in American Indians. Diabetes 73, 1361-1371 (2024)
Mallone, R.* et al. Emerging concepts and success stories in type 1 diabetes research: A roadmap for a bright future. Diabetes 74:12-21 (2024)
Schwarz, D.* et al. Exploring structural and molecular features of sciatic nerve lesions in diabetic neuropathy: Unveiling pathogenic pathways and targets. Diabetes 74, 65-74 (2024)
Wyatt, R.C.* et al. Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays. Diabetes 73, 565-571 (2024)
Nogal, A.* et al. A faecal metabolite signature of impaired fasting glucose: Results from twoindependent population-based cohorts. Diabetes 72, 1870-1880 (2023)
Tsilingiris, D.* et al. Sensory phenotypes provide insight into the natural course of diabetic polyneuropathy. Diabetes 73, 135-146 (2023)
Wagner, R. et al. Lower hepatic fat is associated with improved insulin secretion in a high-risk prediabetes subphenotype during lifestyle intervention. Diabetes 72, 362-366 (2023)
Bediaga, N.G.* et al. Cytotoxicity-related gene expression and chromatin accessibility define a subset of CD4+ T cells that mark progression to type 1 diabetes. Diabetes 71, 566-577 (2022)
Gottmann, P.* et al. Heterogeneous development of β-cell populations In diabetes-resistant and -susceptible mice. Diabetes 71, 1962-1978 (2022)
Kwon, B.C.* et al. Islet autoantibody levels differentiate progression trajectories in individuals with presymptomatic type 1 diabetes. Diabetes 71, 2632-2641 (2022)
Scarale, M.G.* et al. Circulating metabolites associate with and improve the prediction of all-cause mortality in type 2 diabetes. Diabetes 71, 1363-1370 (2022)
Sims, E.K.* et al. Screening for type 1 diabetes in the general population: A status report and perspective. Diabetes 71, 610-623 (2022)
Yamazaki, H.* et al. Fat-distribution patterns and future type-2 diabetes. Diabetes 71, 1937-1945 (2022)
Baboota, R.K.* ; Blüher, M. & Smith, U.* Emerging role of bone morphogenetic protein 4 in metabolic disorders. Diabetes 70, 303-312 (2021)
Chen, J.* et al. CaM kinase II-δ is required for diabetic hyperglycemia and retinopathy but not nephropathy. Diabetes 70, 616-626 (2021)
Eriksson, O.* et al. Drug occupancy assessment at the glucose-dependent insulinotropic polypeptide (GIP) receptor by positron emission tomography. Diabetes 70, 842-853 (2021)
Fritsche, A. et al. Different effects of lifestyle intervention in high- and low-risk prediabetes. Diabetes 70, 2785-2795:2785-2795 (2021)
Herder, C.* et al. Differences in biomarkers of inflammation between novel subgroups of recent-onset diabetes. Diabetes 70, 1198-1208 (2021)
Li, Q.* et al. Plasma metabolome and circulating vitamins stratified onset age of an initial islet autoantibody and progression to type 1 diabetes: The TEDDY Study. Diabetes 70, 282-292 (2021)
Lundsgaard, A.M.* et al. Small amounts of dietary medium-chain fatty acids protect against insulin resistance during caloric excess in humans. Diabetes 70, 91-98 (2021)
Rodriguez-Calvo, T. et al. Altered β-cell prohormone processing and secretion in type 1 diabetes. Diabetes 70, 1038-1050 (2021)
Rodriguez-Calvo, T. ; Krogvold, L.* ; Amirian, N.* ; Dahl-Jørgensen, K.* & von Herrath, M.* One in ten CD8+ cells in the pancreas of living individuals with recent onset type 1 diabetes recognizes the preproinsulin epitope PPI15-24. Diabetes 70, 752-758 (2021)
Tura, A.* et al. Profiles of glucose metabolism in different prediabetes phenotypes, classified by fasting glycemia, 2-hour OGTT, glycated hemoglobin, and 1-hour OGTT: An IMI DIRECT study. Diabetes 70, 2092-2106 (2021)
Buitinga, M.* et al. Non-invasive monitoring of glycemia-induced regulation of GLP-1R expression in murine and human islets of Langerhans. Diabetes 69, 2246-2252 (2020)
Elhadad, M.A. et al. Deciphering the plasma proteome of type 2 diabetes. Diabetes 69, 2766-2778 (2020)
Huang, J. et al. Machine learning approaches reveal metabolic signatures of incident chronic kidney disease in individuals with prediabetes and type 2 diabetes. Diabetes 69, 2756-2765 (2020)
Jende, J.M.E.* et al. Troponin T parallels structural nerve damage in type 2 diabetes: A cross-sectional study using magnetic resonance neurography. Diabetes 69, 713-723 (2020)
Kleinert, M. & Müller, T.D. A new FGF21 analog for the treatment of fatty liver disease. Diabetes 69, 1605-1607 (2020)
Knoop, J. et al. Maternal type 1 diabetes reduces autoantigen-responsive CD4(+) T cells in Offspring. Diabetes 69, 661-669 (2020)
Li, Q.* et al. Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY Study. Diabetes 69, 465-476 (2020)
Rubey, M. et al. DLL1- and DLL4-mediated Notch signaling is essential for adult pancreatic islet homeostasis. Diabetes 69, 915-926 (2020)
Rutter, G.A.* ; Ninov, N. ; Salem, V.* & Hodson, D.J.* Comment on Satin et al. "Take Me To Your Leader": An electrophysiological appraisal of the role of Hhb cells in pancreatic islets. Diabetes 2020;69:830-836. Diabetes 69, E10-E11 (2020)
Yaghootkar, H.* et al. Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity. Diabetes 69, 2806-2818 (2020)
Graae, A.S.* et al. ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations. Diabetes 68, 502-514 (2019)
Groener, J.B.* et al. Understanding diabetic neuropathy: From subclinical nerve lesions to severe nerve fiber deficits. A cross-sectional study in patients with type 2 diabetes and healthy controls. Diabetes 69, 436-447 (2019)
Herrera Moro Chao, D.* et al. The iminosugar AMP-DNM improves satiety and activates brown adipose tissue through GLP1. Diabetes 68, 2223-2234 (2019)
Hippich, M. et al. Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68, 847-857 (2019)
Ji, Y.* et al. Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
Ma, J.* et al. A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for non-alcoholic fatty liver disease. Diabetes 68, 1073-1083 (2019)
Ratner, C.* et al. Long-acting neurotensin synergizes with liraglutide to reverse obesity through a melanocortin-dependent pathway. Diabetes 68, 1329-1340 (2019)
Wittenbecher, C.* et al. Insulin-like growth factor binding protein 2 (IGFBP-2) and the risk of developing type 2 diabetes. Diabetes 68, 188-197 (2019)
Endesfelder, D. et al. Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
Herder, C.* et al. A systemic inflammatory signature reflecting crosstalk between innate and adaptive immunity is associated with polyneuropathy: KORA F4/FF4 Study. Diabetes 67, 2434-2442 (2018)
Kim, T.* et al. Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21. Diabetes 67, 1773-1782 (2018)
Kroeger, J.* et al. Circulating fetuin - A and risk of type 2 diabetes : A mendelian randomization analysis. Diabetes 67, 1200-1205 (2018)
Maczewsky, J.* et al. TGR5 activation promotes stimulus-secretion coupling of pancreatic -cells via a PKA-dependent pathway. Diabetes 67, 324-336:db180315 (2018)
Mueller, K.M.* et al. Erratum. Adipocyte glucocorticoid Receptor deficiency attenuates aging- and HFD-induced obesity and impairs the feeding-fasting transition. Diabetes 2017;66:272-286. Diabetes 67, 343-344 (2018)
Norris, J.M.* et al. Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes 67, 146-154 (2018)
Pfuhlmann, K. et al. Celastrol-induced weight loss is driven by hypophagia and independent from UCP1. Diabetes 67, 2456-2465 (2018)
Salami, F.* et al. Reduction in white blood cell, neutrophil, and red blood cell counts related to sex, HLA, and islet autoantibodies in Swedish TEDDY children at increased risk for type 1 diabetes. Diabetes 67, 2329-2336 (2018)
van Zuydam, N.R.* et al. A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes. Diabetes 67, 1414-1427 (2018)
Adam, J. et al. Response to comment on Adam et al. Metformin effect on nontargeted metabolite profiles in patients with type 2 diabetes and in multiple murine tissues. Diabetes 2016;65:3776-3785. Diabetes 66, e3-e4 (2017)
Bamberg, F.* et al. Subclinical disease burden as assessed by whole-body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: The KORA-MRI study. Diabetes 66, 158-169 (2017)
Gao, Y. et al. Disruption of lipid uptake in astroglia exacerbates diet induced obesity. Diabetes 66, 2555-2563 (2017)
Heni, M. et al. Hypothalamic and striatal insulin action suppresses endogenous glucose production and may stimulate glucose uptake during hyperinsulinemia in lean but not in overweight men. Diabetes 66, 1797-1806 (2017)
Kabra, U.D. et al. Direct substrate delivery into mitochondrial-fission deficient pancreatic islets rescues insulin secretion. Diabetes 66, 1247-1257 (2017)
Kahn, C.R.* & Ussar, S. Response to comment on Ussar et al. Regulation of glucose uptake and enteroendocrine function by the intestinal epithelial insulin receptor. Diabetes 2017;66:886-896. Diabetes 66, e6-e6 (2017)
Klement, J.* et al. Oxytocin improves beta-cell responsivity and glucose tolerance in healthy men. Diabetes 66, 264-271 (2017)
Krischer, J.P.* et al. The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history to the progression from multiple autoantibodies to type 1 diabetes: A TEDDY Study Report. Diabetes 66, 3122-3129 (2017)
Lee, K.Y.* et al. Tbx15 defines a glycolytic subpopulation and white adipocyte heterogeneity. Diabetes 66, 2822-2829 (2017)
Manning, A.* et al. A low-frequency inactivating Akt2 variant enriched in the Finnish population is associated with fasting insulin levels and type 2 diabetes risk. Diabetes 66, 2019-2032 (2017)
Rodriguez-Calvo, T. ; Atkinson, M.* & Von Herrath, M.G.* Response to comment on Rodriguez-Calvo et al. Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. diabetes 2017;66:1334-1345. Diabetes 66, e10-e11 (2017)
Rodriguez-Calvo, T. ; Atkinson, M.* & Von Herrath, M.G.* Response to comment on Rodriguez-Calvo et al. Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes 2017;66:1334–1345. Diabetes 66, e10-e11 (2017)
Scerbo, M.J. & Gerdes, J.M. Bonding with beta-cells-a role for oxytocin in glucose handling. Diabetes 66, 256-257 (2017)
Scott, R.A.* et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66, 2888-2902 (2017)
Tschöp, M.H. & DiMarchi, R.* Single-molecule combinatorial therapeutics for treating obesity and diabetes. In:. Alexandria: Amer Diabetes Assoc, 2017. 1766-1769 (Diabetes ; 66)
Ussar, S. et al. Regulation of glucose uptake and enteroendocrine function by the intestinal epithelial insulin receptor. Diabetes 66, 886-896 (2017)
Varela, L.* et al. Endothelial HIF-1α enables hypothalamic glucose uptake to drive POMC neurons. Diabetes 66, 1511-1520 (2017)
Wagner, R. et al. Nonsuppressed glucagon after glucose challenge as a potential predictor for glucose tolerance. Diabetes 66, 1373-1379 (2017)
Wolf, K. et al. Erratum. Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation, and adipokines (vol 65, pg 3314, 2016). Diabetes 66, 2725-2725 (2017)
Wood, A.R.* et al. A genome-wide association study of IVGTT-based measures of first-phase insulin secretion refines the underlying physiology of type 2 diabetes variants. Diabetes 66, 2296-2309 (2017)
Adam, J. et al. Metformin effect on non-targeted metabolite profiles in patients with type 2 diabetes and multiple murine tissues. Diabetes 65, 3776-3785 (2016)
Böhm, A. et al. TGFβ contributes to impaired exercise response by suppression of mitochondrial key regulators in skeletal muscle. Diabetes 65, 2849-2861 (2016)
Chen, C. et al. Alterations in β-cell calcium dynamics and efficacy outweigh islet mass adaptation in compensation of insulin resistance and prediabetes onset. Diabetes 65, 2676-2685 (2016)
Dahlman, I.* et al. Numerous genes in loci associated with body fat distribution are linked to adipose function. Diabetes 65, 433-437 (2016)
Frankó, A. et al. Bezafibrate improves insulin sensitivity and metabolic flexibility in STZ-treated diabetic mice. Diabetes 65, 2540-2552 (2016)
García-Cáceres, C. & Tschöp, M.H. Hypothalamic injury: Fish oil to the rescue! Diabetes 65, 551-553 (2016)
Ghosh, A.R.* et al. Adipose recruitment and activation of plasmacytoid dendritic cells fuel metaflammation. Diabetes 65, 3440-3452 (2016)
Kruse, M.* et al. A high fat diet during mouse pregnancy and lactation targets GIP-regulated metabolic pathways in adult male offspring. Diabetes 65, 574-584 (2016)
Larsson, H.E.* et al. Growth and risk for islet autoimmunity and progression to type 1 diabetes in early childhood: The Environmental Determinants of Diabetes in the Young Study. Diabetes 65, 1988-1995 (2016)
Mueller, K.M.* et al. Adipocyte glucocorticoid receptor deficiency attenuates aging and HFDinduced obesity, and impairs the feedingfasting transition. Diabetes 66, 272-286:db160381 (2016)
Teumer, A.* et al. Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. Diabetes 65, 803-817 (2016)
Walford, G.A.* et al. Genome-wide association study of the modified Stumvoll Insulin Sensitivity Index identifies BCL2 and FAM19A2 as novel insulin sensitivity loci. Diabetes 65, 3200-3211 (2016)
Wolf, K. et al. Association between long-term exposure to air pollution and biomarkers related to insulin resistance, subclinical inflammation and adipokines. Diabetes 65, 3314-3326 (2016)
Ziegler, A.-G. et al. Type 1 diabetes prevention: A goal dependent on accepting a diagnosis of an asymptomatic disease. Diabetes 65, 3233-3239 (2016)
Chmelova, H. et al. Distinct roles of β-cell mass and function during type 1 diabetes onset and remission. Diabetes 64, 2148-2160 (2015)
Fall, T.* et al. Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes 64, 1841-1852 (2015)
Gancheva, S.* et al. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans. Diabetes 64, 1966-1975 (2015)
Heni, M. ; Wagner, R.* ; Kullmann, S. ; Preissl, H. & Fritsche, A. Response to comment on Heni et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 64, e8-e9 (2015)
Neschen, S. et al. Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice. Diabetes 64, 284-290 (2015)
Ott, V.* et al. Central nervous insulin administration does not potentiate the acute glucoregulatory impact of concurrent mild hyperinsulinemia. Diabetes 64, 760-765 (2015)
Papandonatos, G.D.* et al. Genetic predisposition to weight loss and regain with lifestyle intervention: Analyses from the Diabetes Prevention Program and the Look AHEAD randomized controlled trials. Diabetes 64, 4312-4321 (2015)
Qi, Q.* et al. Dietary intake, FTO genetic variants and adiposity: A combined analysis of over 16,000 children and adolescents. Diabetes 64, 2467-2476 (2015)
Segrè, A.V.* ; Wei, N.* & DIAGRAM Consortium (Florez, J.C* ; Klopp, N. ; Illig, T. ; Müller-Nurasyid, M. ; Peters, A.) Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk. Diabetes 64, 1470-1483 (2015)
Sweetwyne, M.T.* et al. Notch1 and Notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes 64, 4099-4111 (2015)
Törn, C.* et al. Role of Type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes 64, 1818-1829 (2015)
Wiedemann, T. ; Bielohuby, M.* ; Müller, T.D. ; Bidlingmaier, M.* & Pellegata, N.S. Obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity. Diabetes 65, 406-420 (2015)
Williams, A.J.* et al. Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 64, 3239-3246 (2015)
Williams, A.J.* et al. Reactivity to N-terminally truncated GAD65(96-585) identifies GAD autoantibodies that are more closely associated with diabetes progression in relatives of patients with type 1 diabetes. Diabetes 64, 3247-3252 (2015)
Clemmensen, C. et al. GLP-1/glucagon co-agonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet. Diabetes 63, 1422-1427 (2014)
Endesfelder, D. et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006-2014 (2014)
Ferreira, R.C.* et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk of type 1 diabetes. Diabetes 63, 2538-2550 (2014)
Habegger, K.M.* et al. GLP-1R responsiveness predicts individual gastric bypass efficacy on glucose tolerance in rats. Diabetes 63, 505-513 (2014)
Heni, M. et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes 63, 4083-4088 (2014)
Heppner, K.M.* et al. Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via CNS ghrelin receptors. Diabetes 63, 122-131 (2014)
Herder, C.* et al. Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits. Diabetes 63, 4343-4359 (2014)
Keildson, S.* et al. Expression of phosphofructokinase in skeletal muscle is influenced by genetic variation and associated with insulin sensitivity. Diabetes 63, 1154-1165 (2014)
Tong, J.* et al. Acute administration of unacylated ghrelin has no effect on basal or stimulated insulin secretion in healthy humans. Diabetes 63, 2309-2319 (2014)
Dimas, A.S.* et al. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63, 2158-2171 (2013)
Ferrannini, E.* et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62, 1730-1737 (2013)
Floegel, A.* et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648 (2013)
Habegger, K.M.* et al. Fibroblast growth factor 21 mediates specific glucagon actions. Diabetes 62, 1453-1463 (2013)
Habegger, K.M.* et al. GLP-1R agonism enhances adjustable gastric banding in diet-induced obese rats. Diabetes 62, 3261-3267 (2013)
Heni, M. ; Kullmann, S. & Fritsche, A. Comment on: Teeuwisse et al. Short-term caloric restriction normalizes hypothalamic neuronal responsiveness to glucose ingestion in patients with type 2 diabetes. Diabetes 2012;61:3255-3259. Diabetes 62:e5 (2013)
Heninger, A.K.* et al. Activation of islet autoreactive naive T cells in infants is influenced by homeostatic mechanisms and antigen presenting capacity. Diabetes 62, 2059-2066 (2013)
Li, H.* et al. A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese Hans. Diabetes 62, 291-298 (2013)
Menni, C.* et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach. Diabetes 62, 4270-4276 (2013)
Monti, P.* ; Brigatti, C.* ; Krasmann, M. ; Ziegler, A.-G. & Bonifacio, E.* Concentration and activity of the soluble form of the interleukin-7 receptor α in type I diabetes identifies an interplay between hyperglycemia and immune function. Diabetes 62, 2500-2508 (2013)
Ott, V.* et al. Oxytocin reduces reward-driven food intake in humans. Diabetes 62, 3418-3425 (2013)
Renner, S.* et al. Permanent neonatal diabetes in INSC94Y transgenic pigs. Diabetes 62, 1505-1511 (2013)
Saxena, R.* et al. Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes 62, 1746-1755 (2013)
Tabassum, R.* et al. Genome-wide association study for type 2 diabetes in Indians identifies a new susceptibility locus at 2q21. Diabetes 62, 977-986 (2013)
Wagner, R. et al. Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans. Diabetes 62, 2106-2111 (2013)
Xie, W.* et al. Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 62, 2141-2150 (2013)
Billings, L.K.* et al. Impact of common variation in bone-related genes on type 2 diabetes and related traits. Diabetes 61, 2176-2186 (2012)
Marquez, M.* et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 61, 524-530 (2012)
Renner, S.* et al. Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass. Diabetes 61, 2166-2175 (2012)
Tschöp, M.H. & DiMarchi, R.D.* Outstanding scientific achievement award lecture 2011: Defeating diabesity: The case for personalized combinatorial therapies. Diabetes 61, 1309-1314 (2012)
Yi, C.-X. et al. Glucocorticoid signaling in the arcuate nucleus modulates hepatic insulin sensitivity. Diabetes 61, 339-345 (2012)
Ziegler, A.-G. et al. Long-term protective effect of lactation on the development of type 2 diabetes in women with recent gestational diabetes mellitus. Diabetes 61, 3167-3171 (2012)
Bonifacio, E. ; Warncke, K. ; Winkler, C. ; Wallner, M.* & Ziegler, A.-G. Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk. Diabetes 60, 3300-3306 (2011)
Hivert, M.F.* et al. Updated genetic score based on 34 confirmed type 2 diabetes loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60, 1340-1348 (2011)
Kanoni, S.* et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: A 14-cohort meta-analysis. Diabetes 60, 2407-2416 (2011)
Pflueger, M. et al. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 60, 2740-2747 (2011)
Renström, F.* et al. Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes 60, 345-354 (2011)
Strawbridge, R.J.* et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60, 2624-2634 (2011)
Winkler, C. et al. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes 60, 685-690 (2011)
Soranzo, N.* et al. Common variants at 10 genomic loci influence hemoglobin A₁C levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239 (2010)
Winkler, C. et al. BMI at age 8 years is influenced by the type 2 diabetes susceptibility genes HHEX-IDE and CDKAL1. Diabetes 59, 2063-2067 (2010)
Laumen, H.* et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 58, 984-991 (2009)
Wiedmann, S.* et al. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57, 209-217 (2008)
Herbach, N.* et al. Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe ß-Cell Loss in Munich Ins2C95S Mutant Mice. Diabetes 56, 1268-1276 (2007)
Endl, J.* et al. Co-expression of CD25 and Ox40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55, 50-60 (2006)
Gray, S.L.* et al. Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55, 2669-2677 (2006)
Heid, I.M. et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels anmd parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55, 375-384 (2006)
Huth, C. et al. IL6 gene promoter polymorphisms and type 2 diabetes: Joint analysis of individual participants' data from 21 studies. Diabetes 55, 2915-2921 (2006)
Schoenborn, V.* et al. The ATGL gene is associated with free fatty acids, triglycerides and type 2 diabetes. Diabetes 55, 1270-1275 (2006)
Baessler, A.* & Döring, A. Genetic linkage and association of the growth hormone secretagogue receptor (Ghrelin receptor) gene in human obesity. Diabetes 54, 259-267 (2005)
Herder, Ch.* et al. Association of Systemic Chemokine Concentrations with Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54, 2, 11-17 (2005)
Thorand, B. et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54, 2932-2938 (2005)
Cabeza, N.* et al. Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53, 2117-2121 (2004)
Illig, T. et al. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52, 2861-2864 (2003)
Ruprecht, L. ; Illini, P. & Funke, H. Investigations on Sheep and Dog Concerning the Correlation of Subcutaneous Glucose Concentration and Plasma Glucose Concentration. Diabetes (1986)